CO6541613A2 - Combinaciones de un antagonista de los receptores muscarínicos y un agonista del adreno-receptor beta 2 - Google Patents
Combinaciones de un antagonista de los receptores muscarínicos y un agonista del adreno-receptor beta 2Info
- Publication number
- CO6541613A2 CO6541613A2 CO12088319A CO12088319A CO6541613A2 CO 6541613 A2 CO6541613 A2 CO 6541613A2 CO 12088319 A CO12088319 A CO 12088319A CO 12088319 A CO12088319 A CO 12088319A CO 6541613 A2 CO6541613 A2 CO 6541613A2
- Authority
- CO
- Colombia
- Prior art keywords
- beta
- combinations
- antagonist
- adreno
- muscarinic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
- B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
- B65D75/36—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Se proporcionan combinaciones novedosas de un antagonista de los receptores muscarínicos de acetil-colina y un agonista beta-2 para su administración inhalada por medio de la nariz o la boca, y métodos para su uso.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0921075.8A GB0921075D0 (en) | 2009-12-01 | 2009-12-01 | Novel combination of the therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6541613A2 true CO6541613A2 (es) | 2012-10-16 |
Family
ID=41573013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO12088319A CO6541613A2 (es) | 2009-12-01 | 2012-05-28 | Combinaciones de un antagonista de los receptores muscarínicos y un agonista del adreno-receptor beta 2 |
Country Status (40)
Country | Link |
---|---|
US (7) | US20120309725A1 (es) |
EP (2) | EP2506844B1 (es) |
JP (1) | JP5816631B2 (es) |
KR (2) | KR101742140B1 (es) |
CN (2) | CN102724974A (es) |
AU (6) | AU2010326798B2 (es) |
BR (1) | BR112012012925A2 (es) |
CA (1) | CA2781487C (es) |
CL (1) | CL2012001432A1 (es) |
CO (1) | CO6541613A2 (es) |
CR (1) | CR20120265A (es) |
CY (2) | CY1120058T1 (es) |
DK (1) | DK2506844T3 (es) |
DO (1) | DOP2012000148A (es) |
EA (1) | EA023839B1 (es) |
ES (1) | ES2659330T3 (es) |
FR (1) | FR18C1022I2 (es) |
GB (1) | GB0921075D0 (es) |
HK (1) | HK1249407A1 (es) |
HR (1) | HRP20180312T1 (es) |
HU (2) | HUE036216T2 (es) |
IL (1) | IL219893A (es) |
LT (2) | LT2506844T (es) |
LU (1) | LUC00077I2 (es) |
MA (1) | MA33853B1 (es) |
ME (1) | ME02965B (es) |
MX (1) | MX351290B (es) |
MY (1) | MY184864A (es) |
NO (1) | NO2506844T3 (es) |
NZ (1) | NZ600026A (es) |
PE (2) | PE20130042A1 (es) |
PL (1) | PL2506844T3 (es) |
PT (1) | PT2506844T (es) |
RS (1) | RS56848B1 (es) |
SG (2) | SG181087A1 (es) |
SI (1) | SI2506844T1 (es) |
TR (1) | TR201802921T4 (es) |
UA (1) | UA106775C2 (es) |
WO (1) | WO2011067212A1 (es) |
ZA (1) | ZA201203890B (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY28871A1 (es) | 2004-04-27 | 2005-11-30 | Glaxo Group Ltd | Antagonistas del receptor de acetilcolina muscarinico |
SI2400950T1 (sl) | 2009-02-26 | 2019-09-30 | Glaxo Group Limited | Farmacevtske forlmulacije, ki obsegajo 4-((1 R)-2-((6-(2-((2,6- diklorobenzil)oksi)etoksi)heksil)amino)-1-hidroksietil)-2- (hidroksimetil)fenol |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
WO2012028663A1 (en) * | 2010-08-31 | 2012-03-08 | Glaxo Group Limited | Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same |
MX2013014399A (es) * | 2011-06-08 | 2014-03-21 | Glaxo Group Ltd | Combinacion que comprende umeclidinio y un corticosteroide. |
CN103561731A (zh) * | 2011-06-08 | 2014-02-05 | 葛兰素集团有限公司 | 包含芜地溴铵的干粉吸入器组合物 |
ES2814336T3 (es) * | 2012-04-13 | 2021-03-26 | Glaxosmithkline Ip Dev Ltd | Partículas de agregado |
GB201222679D0 (en) * | 2012-12-17 | 2013-01-30 | Glaxo Group Ltd | Pharmaceutical combination products |
GB201305825D0 (en) | 2013-03-28 | 2013-05-15 | Vectura Ltd | New use |
ES2959699T3 (es) * | 2014-05-28 | 2024-02-27 | Glaxosmithkline Ip Dev Ltd | Furoato de fluticasona en el tratamiento de la EPOC |
TR201407010A2 (tr) | 2014-06-16 | 2015-12-21 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Vilanterol formülasyonları. |
EP2957552B1 (en) | 2014-06-16 | 2020-01-22 | Arven Ilac Sanayi Ve Ticaret A.S. | Vilanterol formulations |
CA2952760A1 (en) | 2014-06-18 | 2015-12-23 | Cipla Limited | Pharmaceutical composition comprising a beta-2-agonist and anticholinergic agent |
WO2020100040A1 (en) * | 2018-11-12 | 2020-05-22 | 3M Innovative Properties Company | Umeclidinium and vilanterol formulation and inhaler |
CN111840256A (zh) * | 2019-04-29 | 2020-10-30 | 上海谷森医药有限公司 | 一种雾化吸入剂及其制备方法 |
WO2020237151A1 (en) | 2019-05-23 | 2020-11-26 | Huang Cai Gu | Inhalable formulation of a solution containing vilanterol trifenatate and umeclidinium bromide |
WO2021252577A1 (en) * | 2020-06-09 | 2021-12-16 | Anovent Pharmaceutical (U.S.), Llc | Pharmaceutical formulation containing umeclidinium bromide and vilanterol trifenatate |
Family Cites Families (181)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB124009A (en) | 1918-01-12 | 1919-03-12 | Walter Edward Kimber | Improvements in and connected with the Manufacture of Tools for Turning, Planing, Boring and similar purposes. |
GB124010A (en) | 1919-01-10 | 1919-03-20 | Rene Emile Dior | Improved Process for the Manufacture of Synthetic Resins. |
GB1242211A (en) | 1967-08-08 | 1971-08-11 | Fisons Pharmaceuticals Ltd | Pharmaceutical composition |
GB1381872A (en) | 1971-06-22 | 1975-01-29 | Fisons Ltd | Pharmaceutical compositions for inhalation |
GB1424432A (en) | 1972-03-25 | 1976-02-11 | Degussa | Pharmaceutical compositions |
GB2064336B (en) | 1979-12-06 | 1984-03-14 | Glaxo Group Ltd | Device for dispensing medicaments |
ATE23272T1 (de) | 1981-07-08 | 1986-11-15 | Draco Ab | Pulverinhalator. |
GB2169265B (en) | 1982-10-08 | 1987-08-12 | Glaxo Group Ltd | Pack for medicament |
AU570013B2 (en) | 1982-10-08 | 1988-03-03 | Glaxo Group Limited | Medicament inhaler |
US4778054A (en) | 1982-10-08 | 1988-10-18 | Glaxo Group Limited | Pack for administering medicaments to patients |
AU591152B2 (en) | 1985-07-30 | 1989-11-30 | Glaxo Group Limited | Devices for administering medicaments to patients |
GB8530365D0 (en) | 1985-12-10 | 1986-01-22 | Univ Bath | Manufacture of moulded products |
IT1204826B (it) | 1986-03-04 | 1989-03-10 | Chiesi Farma Spa | Composizioni farmaceutiche per inalazione |
CA1329526C (en) | 1987-08-20 | 1994-05-17 | Hiroshi Ikura | Powdery medicine applicator device |
US4994276A (en) | 1988-09-19 | 1991-02-19 | Edward Mendell Co., Inc. | Directly compressible sustained release excipient |
GB8820353D0 (en) | 1988-08-26 | 1988-09-28 | Staniforth J N | Controlled release tablet |
US5135757A (en) | 1988-09-19 | 1992-08-04 | Edward Mendell Co., Inc. | Compressible sustained release solid dosage forms |
US5376386A (en) | 1990-01-24 | 1994-12-27 | British Technology Group Limited | Aerosol carriers |
HU213221B (en) | 1990-03-02 | 1997-03-28 | Glaxo Group Ltd | Inhalation device and medicine packet for device |
US6536427B2 (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
UA26230A (uk) | 1990-03-02 | 1999-07-19 | Глексо Груп Лімітед | Іhгалятор для спільhого використаhhя з лікувальhим блоком і лікувальhий блок |
FR2660634B1 (fr) | 1990-04-06 | 1992-10-16 | Airsec Ind Sa | Conditionnement pour produits necessitant l'usage d'un agent deshydratant. |
JPH0471560A (ja) | 1990-07-10 | 1992-03-06 | Mect Corp | 包装体 |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
DE4140689B4 (de) | 1991-12-10 | 2007-11-22 | Boehringer Ingelheim Kg | Inhalationspulver und Verfahren zu ihrer Herstellung |
EP0611567B1 (en) | 1992-06-12 | 2002-08-28 | Teijin Limited | Ultrafine powder for inhalation and production thereof |
EP0606486B1 (en) | 1992-06-12 | 2001-08-29 | Teijin Limited | Pharmaceutical preparation for intra-airway administration |
GB2269992A (en) | 1992-08-14 | 1994-03-02 | Rh Ne Poulenc Rorer Limited | Powder inhalation formulations |
CA2144163A1 (en) | 1992-09-09 | 1994-03-17 | Fisons Limited | Pharmaceutical packaging |
SE9203743D0 (sv) | 1992-12-11 | 1992-12-11 | Astra Ab | Efficient use |
UA27961C2 (uk) | 1992-12-18 | 2000-10-16 | Шерінг Корпорейшн | Інгалятор для порошкових ліків |
US5441060A (en) | 1993-02-08 | 1995-08-15 | Duke University | Dry powder delivery system |
DE69413955T2 (de) | 1993-03-17 | 1999-04-01 | Minnesota Mining & Mfg | Aerosolzusammensetzung enthaltend einen aus ester-, amid- oder merkaptoester- derivat dispergiermittel |
US5730785A (en) | 1993-04-01 | 1998-03-24 | Multisorb Technologies, Inc. | Desiccant canister for desiccants and other particulate material |
US5506203C1 (en) | 1993-06-24 | 2001-02-06 | Astra Ab | Systemic administration of a therapeutic preparation |
IS1796B (is) | 1993-06-24 | 2001-12-31 | Ab Astra | Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband |
DE4323636A1 (de) | 1993-07-15 | 1995-01-19 | Hoechst Ag | Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung |
GB9322014D0 (en) | 1993-10-26 | 1993-12-15 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
US5503662A (en) | 1994-03-29 | 1996-04-02 | Multiform Desiccants, Inc. | Canister with porous plastic ends |
FI95441C (fi) | 1994-05-31 | 1996-02-12 | Leiras Oy | Inhalointilaitteen lääkeainekammio |
US6156231A (en) | 1994-09-08 | 2000-12-05 | Multisorb Technologies, Inc. | Oxygen absorbing composition with cover layer |
US5641425A (en) | 1994-09-08 | 1997-06-24 | Multiform Desiccants, Inc. | Oxygen absorbing composition |
SA95160463B1 (ar) | 1994-12-22 | 2005-10-04 | استرا أكتيبولاج | مساحيق للاستنشاق |
GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
US6279736B1 (en) | 1995-04-19 | 2001-08-28 | Capitol Specialty Plastics, Inc. | Barrier pack having an absorbing agent applied to the interior of the pack |
CN1185139A (zh) | 1995-04-19 | 1998-06-17 | 金圆玻璃容器有限公司 | 包含在封闭容器内的干燥材料 |
GB9515182D0 (en) | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
GB9700226D0 (en) | 1997-01-08 | 1997-02-26 | Glaxo Group Ltd | Inhalation device |
US6103141A (en) | 1997-01-23 | 2000-08-15 | Multisorb Technologies, Inc. | Desiccant deposit |
US6126919A (en) | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
WO1998040169A1 (en) | 1997-03-14 | 1998-09-17 | The University Of Houston | Methods for making fluorinated surface modifying agents, methods of using same and products made using same |
US5985415A (en) | 1997-11-17 | 1999-11-16 | Reconnx, Inc. | Finger joint architecture for wood products, and method and apparatus for formation thereof |
US6086376A (en) | 1998-01-30 | 2000-07-11 | Rtp Pharma Inc. | Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
CA2319736C (en) | 1998-02-05 | 2009-01-27 | E.I. Du Pont De Nemours And Company | Water purification apparatus |
HUP0101608A2 (hu) | 1998-04-18 | 2002-03-28 | Glaxo Group Limited | Aeroszol formájú gyógyszerkészítmény és eljárás előállítására |
US7521068B2 (en) | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
ATE382386T1 (de) | 1998-11-13 | 2008-01-15 | Jagotec Ag | Multidosis-trockenpulverinhalator mit pulverreservoir |
US20070212422A1 (en) | 1999-11-10 | 2007-09-13 | Manfred Keller | Dry powder for inhalation |
GB9827145D0 (en) | 1998-12-09 | 1999-02-03 | Co Ordinated Drug Dev | Improvements in or relating to powders |
US6352152B1 (en) | 1998-12-18 | 2002-03-05 | Smithkline Beecham Corporation | Method and package for storing a pressurized container containing a drug |
US6390291B1 (en) | 1998-12-18 | 2002-05-21 | Smithkline Beecham Corporation | Method and package for storing a pressurized container containing a drug |
US6119853A (en) | 1998-12-18 | 2000-09-19 | Glaxo Wellcome Inc. | Method and package for storing a pressurized container containing a drug |
US6315112B1 (en) | 1998-12-18 | 2001-11-13 | Smithkline Beecham Corporation | Method and package for storing a pressurized container containing a drug |
WO2001097888A2 (en) | 2000-06-22 | 2001-12-27 | Glaxo Group Limited | Method and package for storing a pressurized container containing a drug |
EP1158958B1 (en) | 1999-03-05 | 2007-06-06 | CHIESI FARMACEUTICI S.p.A. | Improved powdery pharmaceutical compositions for inhalation |
IT1309592B1 (it) | 1999-03-05 | 2002-01-24 | Chiesi Farma Spa | Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e |
USD440874S1 (en) | 1999-07-29 | 2001-04-24 | The Gillette Company | Container |
ATE259868T1 (de) | 1999-10-11 | 2004-03-15 | Innovata Biomed Ltd | Medikamentenabgabevorrichtung mit einer feuchtigkeitsbeständigen beschichtung |
DE19957802A1 (de) | 1999-12-01 | 2001-06-07 | Trw Repa Gmbh | Gurtaufrollersystem |
GB0008660D0 (en) | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
JP2003531123A (ja) | 2000-04-13 | 2003-10-21 | イノバータ・バイオミッド・リミテッド | 医薬品 |
PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
WO2001087731A2 (en) | 2000-05-15 | 2001-11-22 | Glaxo Group Limited | Aerosol mdi overcap containing desiccant |
GB0015043D0 (en) | 2000-06-21 | 2000-08-09 | Glaxo Group Ltd | Medicament dispenser |
US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
AU2001275760B2 (en) | 2000-08-05 | 2005-03-17 | Glaxo Group Limited | 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid S-fluoromethyl ester as an anti-inflammatory agent |
DE10056855A1 (de) | 2000-11-16 | 2002-05-29 | Lohmann Therapie Syst Lts | Verbundlaminat mit Sauerstoff und Feuchtigkeit absorbierender Schicht und Verfahren zu seiner Herstellung |
WO2002043700A2 (en) | 2000-11-30 | 2002-06-06 | Vectura Limited | Particles for use in a pharmaceutical composition |
EP2298279B1 (en) | 2000-11-30 | 2018-11-14 | Vectura Limited | Pharmaceutical compositions for inhalation |
EP1241110A1 (en) | 2001-03-16 | 2002-09-18 | Pfizer Products Inc. | Dispensing unit for oxygen-sensitive drugs |
EP1243524A3 (en) | 2001-03-16 | 2004-04-07 | Pfizer Products Inc. | Pharmaceutical kit for oxygen-sensitive drugs |
UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
DE10126924A1 (de) | 2001-06-01 | 2002-12-05 | Boehringer Ingelheim Pharma | Inhalationskapseln |
BRPI0212455B8 (pt) * | 2001-09-14 | 2021-05-25 | Glaxo Group Ltd | composto derivado de fenetanolamina para o tratamento de doenças respiratórias, formulação farmacêutica, combinação, e, uso do mesmo |
WO2003057593A1 (en) | 2001-12-21 | 2003-07-17 | Nektar Therapeutics | Capsule package with moisture barrier |
GB0201677D0 (en) | 2002-01-25 | 2002-03-13 | Glaxo Group Ltd | Medicament dispenser |
GB0208608D0 (en) * | 2002-04-13 | 2002-05-22 | Glaxo Group Ltd | Composition |
US20030203141A1 (en) | 2002-04-25 | 2003-10-30 | Blum John B. | Blister package |
US20030235664A1 (en) | 2002-06-20 | 2003-12-25 | Rick Merical | Films having a desiccant material incorporated therein and methods of use and manufacture |
US8003179B2 (en) | 2002-06-20 | 2011-08-23 | Alcan Packaging Flexible France | Films having a desiccant material incorporated therein and methods of use and manufacture |
US20040131805A1 (en) | 2002-06-20 | 2004-07-08 | Merical Rick L. | Films having a desiccant material incorporated therein and methods of use and manufacture |
US20060269708A1 (en) | 2002-06-20 | 2006-11-30 | Rick Merical | Films having a desiccant material incorporated therein and methods of use and manufacture |
US20060236868A1 (en) | 2003-05-19 | 2006-10-26 | Bester Pansegrouw | Dessicant container |
GB0312148D0 (en) | 2003-05-28 | 2003-07-02 | Aventis Pharma Ltd | Stabilized pharmaceutical products |
SE527191C2 (sv) | 2003-06-19 | 2006-01-17 | Microdrug Ag | Inhalatoranordning samt kombinerade doser av tiotropium och fluticason |
GB0315889D0 (en) | 2003-07-08 | 2003-08-13 | Aventis Pharma Ltd | Stable pharmaceutical products |
EP1641437A4 (en) | 2003-07-09 | 2009-06-03 | Chong Kun Dang Pharm Corp | SOLID DISPERSION OF TACROLIMUS |
GB0316341D0 (en) | 2003-07-11 | 2003-08-13 | Glaxo Group Ltd | Pharmaceutical formulations |
WO2005004845A1 (en) | 2003-07-11 | 2005-01-20 | Glaxo Group Limited | Pharmaceutical formulations comprising magnesium stearate |
US20050072958A1 (en) | 2003-10-02 | 2005-04-07 | Thomas Powers | Oxygen scavenger for low moisture environment and methods of using the same |
AR046103A1 (es) * | 2003-10-14 | 2005-11-23 | Glaxo Group Ltd | Compuesto de 8-azoniabiciclo [3.2.1] octano,composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos y uso del compuesto para preparar dicha composicion |
WO2005044186A2 (en) | 2003-10-28 | 2005-05-19 | Glaxo Group Limited | Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same |
GB0326632D0 (en) * | 2003-11-14 | 2003-12-17 | Jagotec Ag | Dry powder formulations |
SE0303270L (sv) | 2003-12-03 | 2005-06-04 | Microdrug Ag | Metod för administration av tiotropium |
SE0303569L (sv) | 2003-12-03 | 2005-06-04 | Microdrug Ag | DPI för avlämning av fuktkänsliga medikament |
EP1691782A1 (en) | 2003-12-03 | 2006-08-23 | Microdrug AG | Medical product containing tiotropium |
SE0303269L (sv) | 2003-12-03 | 2005-06-04 | Microdrug Ag | Medicinsk produkt |
SE0303570L (sv) | 2003-12-03 | 2005-06-04 | Microdrug Ag | Fukt-känslig medicinsk produkt |
JP2007512898A (ja) | 2003-12-03 | 2007-05-24 | マイクロドラッグ アクチェンゲゼルシャフト | 湿度に過敏な薬剤向けの予め計量されたドライパウダー吸入器 |
GB2410192B (en) | 2004-01-23 | 2005-12-07 | Eg Technology Ltd | An inhaler |
UY28871A1 (es) | 2004-04-27 | 2005-11-30 | Glaxo Group Ltd | Antagonistas del receptor de acetilcolina muscarinico |
GB0409703D0 (en) | 2004-04-30 | 2004-06-02 | Vectura Ltd | Pharmaceutical compositions |
RU2379033C2 (ru) | 2004-05-31 | 2010-01-20 | Лабораториос Альмираль, С.А. | Комбинации, содержащие антимускариновые средства и бета-адренергические агонисты |
ES2257152B1 (es) | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos. |
SE530006C2 (sv) | 2004-06-18 | 2008-02-05 | Mederio Ag | Inhalator som använder balja |
SE0401654D0 (sv) | 2004-06-24 | 2004-06-24 | Astrazeneca Ab | A support structure for a medicament |
GB0416397D0 (en) | 2004-07-22 | 2004-08-25 | Glaxo Group Ltd | Pharmaceutical formulations |
JP2008510014A (ja) | 2004-08-16 | 2008-04-03 | セラヴァンス, インコーポレーテッド | β2アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有する化合物 |
JP5566576B2 (ja) | 2004-10-21 | 2014-08-06 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 吸入器用ブリスタ |
US7501011B2 (en) | 2004-11-09 | 2009-03-10 | Multisorb Technologies, Inc. | Humidity control device |
SE0402976L (sv) | 2004-12-03 | 2006-06-04 | Mederio Ag | Medicinsk produkt |
PE20061162A1 (es) | 2004-12-06 | 2006-10-14 | Smithkline Beecham Corp | Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos |
PE20060826A1 (es) | 2004-12-06 | 2006-10-08 | Smithkline Beecham Corp | Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende |
WO2006063050A1 (en) | 2004-12-08 | 2006-06-15 | Perfecseal, Inc. | A sterilizable package with a high barrier to oxygen |
JP2008525527A (ja) | 2004-12-27 | 2008-07-17 | キング・ファーマシューティカルズ・リサーチ・アンド・デベロプメント・インコーポレイティッド | 脱酸素剤を有していてもよい酸素不浸透性包装の安定化甲状腺ホルモン組成物及び甲状腺ホルモン医薬組成物保管のためのその方法 |
US20060144733A1 (en) | 2004-12-30 | 2006-07-06 | 3M Innovative Properties Company | Container assembly and method for humidity control |
WO2006086130A2 (en) | 2005-02-10 | 2006-08-17 | Glaxo Group Limited | Process for crystallizing lactose particles for use in pharmaceutical formulations |
EP1848444B1 (en) | 2005-02-10 | 2016-11-09 | Glaxo Group Limited | Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom |
DE202005002409U1 (de) | 2005-02-15 | 2005-07-07 | Microdrug Ag | Inhalierbares Tiotropium und Behälter dafür |
DE202005004659U1 (de) | 2005-03-22 | 2005-07-07 | Microdrug Ag | Vordosierter Trockenpulverinhalator für feuchtigkeitsempfindliche Medikamente |
GB0507165D0 (en) | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
JP4659523B2 (ja) | 2005-04-26 | 2011-03-30 | 共同印刷株式会社 | ブリスター用フィルム及びブリスター用包装容器 |
WO2006124556A2 (en) | 2005-05-13 | 2006-11-23 | Glaxo Group Limited | Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same |
DE102005022862A1 (de) | 2005-05-18 | 2006-12-14 | Airsec S.A.S | Kapseln für Inhalatoren |
GB0523653D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
US20060278965A1 (en) | 2005-06-10 | 2006-12-14 | Foust Donald F | Hermetically sealed package and methods of making the same |
GB0515584D0 (en) | 2005-07-28 | 2005-09-07 | Glaxo Group Ltd | Medicament dispenser |
CA2623658A1 (en) | 2005-09-28 | 2007-04-05 | Mederio Ag | Inhaler device for moisture sensitive drugs and method of operating an inhaler device |
GB0520794D0 (en) | 2005-10-12 | 2005-11-23 | Innovata Biomed Ltd | Inhaler |
DE502005006831D1 (de) | 2005-10-18 | 2009-04-23 | Alcan Tech & Man Ltd | Kaltverformbares Laminat für Blisterbodenteile |
EP1787800A1 (de) | 2005-11-17 | 2007-05-23 | Alcan Technology & Management Ltd. | Kaltverformbares Laminat für Blisterbodenteile |
AR058289A1 (es) | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | Colector para ser usado en dispensador de medicamento |
US20090012132A1 (en) | 2006-02-27 | 2009-01-08 | Takeda Pharmaceutical Company Limited | Pharmaceutical Package |
KR100764640B1 (ko) | 2006-03-08 | 2007-10-10 | 세원셀론텍(주) | 지방조직 수복용 키트 |
US20090308772A1 (en) | 2006-03-17 | 2009-12-17 | Abrams William S | Moisture-tight primary packaging for a dry powder inhaler |
CA2646236A1 (en) | 2006-03-22 | 2007-09-27 | Glaxo Group Limited | Novel formulations |
CA2646578A1 (en) | 2006-03-22 | 2007-10-18 | 3M Innovative Properties Company | Novel formulations |
AU2006341188A1 (en) | 2006-03-24 | 2007-10-04 | Ian Simon Tracton | Stable packaged dosage form and process therefor |
WO2007135024A1 (en) | 2006-05-24 | 2007-11-29 | Boehringer Ingelheim International Gmbh | New long-acting drug combinations for the treatment of respiratory diseases |
GB0615108D0 (en) | 2006-07-28 | 2006-09-06 | Glaxo Group Ltd | Novel formulations |
US20090314664A1 (en) | 2006-08-03 | 2009-12-24 | Merck Patent Gmbh | Pack Containing Pharmaceutical Administration Forms |
US20090298742A1 (en) | 2006-08-09 | 2009-12-03 | Glaxo Group Limited | Process for manufacturing lactose |
WO2008021142A2 (en) | 2006-08-09 | 2008-02-21 | Glaxo Group Limited | Process for manufacturing lactose |
FI20065636A0 (fi) | 2006-10-04 | 2006-10-04 | Lab Pharma Ltd | Dessikanttijärjestelmä irtohaloitavien jauheiden kosteuden säätämiseksi |
US20100099651A1 (en) | 2006-10-26 | 2010-04-22 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
US20080178559A1 (en) | 2007-01-26 | 2008-07-31 | Multisorb Technologies, Inc. | Sorbent Packaging |
US8034739B2 (en) | 2007-03-29 | 2011-10-11 | Multisorb Technologies, Inc. | Method for selecting adsorptive composite barriers for packaging applications |
US7549272B2 (en) | 2007-04-16 | 2009-06-23 | Multisorb Technologies, Inc. | Sorbent canister with beveled edges |
US20100319303A1 (en) | 2007-05-07 | 2010-12-23 | Airsec | Container with moisture control capacity |
UY31233A1 (es) | 2007-07-21 | 2009-03-02 | Unidades de envasado con un agente desecante | |
PE20090907A1 (es) | 2007-07-21 | 2009-08-05 | Boehringer Ingelheim Int | Nuevos medicamentos pulverulentos que contienen tiotropio y salmeterol, asi como lactosa como excipiente |
WO2009029029A1 (en) | 2007-08-24 | 2009-03-05 | Astrazeneca Ab | Inhaler for powdered substances with desiccant compartment |
KR20100063116A (ko) | 2007-09-12 | 2010-06-10 | 글락소 그룹 리미티드 | 치료제들의 복합제 |
EP2080523A1 (en) | 2008-01-15 | 2009-07-22 | CHIESI FARMACEUTICI S.p.A. | Compositions comprising an antimuscarinic and a long-acting beta-agonist |
EP2254630A1 (de) | 2008-02-20 | 2010-12-01 | Boehringer Ingelheim International GmbH | Pulverinhalatoren |
JP4983657B2 (ja) | 2008-03-11 | 2012-07-25 | 富士通株式会社 | 電子メール管理プログラム、該プログラムを記録した記録媒体、通信端末、および電子メール管理方法 |
EP2127628A1 (en) | 2008-05-27 | 2009-12-02 | Ranbaxy Laboratories Limited | Unit dose pack |
US9095324B2 (en) | 2008-06-20 | 2015-08-04 | Boston Scientific Scimed, Inc. | Package assembly |
PE20110598A1 (es) | 2008-10-02 | 2011-08-31 | Respivert Ltd | Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38 |
UY32297A (es) | 2008-12-22 | 2010-05-31 | Almirall Sa | Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico |
WO2010097114A1 (en) | 2009-02-26 | 2010-09-02 | Glaxo Group Limited | Novel combination of therapeutic agents |
SI2400950T1 (sl) * | 2009-02-26 | 2019-09-30 | Glaxo Group Limited | Farmacevtske forlmulacije, ki obsegajo 4-((1 R)-2-((6-(2-((2,6- diklorobenzil)oksi)etoksi)heksil)amino)-1-hidroksietil)-2- (hidroksimetil)fenol |
US8985102B2 (en) | 2009-05-18 | 2015-03-24 | Adamis Pharmaceuticals Corporation | Dry powder inhalers |
DK2277799T3 (da) | 2009-07-23 | 2012-05-21 | Airsec Sas | Hydreret fugtighedsbekæmpelsesstof og fremgangsmåde til fremstilling deraf |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
WO2012028663A1 (en) | 2010-08-31 | 2012-03-08 | Glaxo Group Limited | Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same |
MX2013014399A (es) | 2011-06-08 | 2014-03-21 | Glaxo Group Ltd | Combinacion que comprende umeclidinio y un corticosteroide. |
CN103561731A (zh) | 2011-06-08 | 2014-02-05 | 葛兰素集团有限公司 | 包含芜地溴铵的干粉吸入器组合物 |
GB201222679D0 (en) | 2012-12-17 | 2013-01-30 | Glaxo Group Ltd | Pharmaceutical combination products |
-
2009
- 2009-12-01 GB GBGB0921075.8A patent/GB0921075D0/en not_active Ceased
-
2010
- 2010-11-29 WO PCT/EP2010/068429 patent/WO2011067212A1/en active Application Filing
- 2010-11-29 NO NO10781527A patent/NO2506844T3/no unknown
- 2010-11-29 DK DK10781527.6T patent/DK2506844T3/en active
- 2010-11-29 EP EP10781527.6A patent/EP2506844B1/en active Active
- 2010-11-29 PL PL10781527T patent/PL2506844T3/pl unknown
- 2010-11-29 MY MYPI2012700331A patent/MY184864A/en unknown
- 2010-11-29 HU HUE10781527A patent/HUE036216T2/hu unknown
- 2010-11-29 MX MX2012006310A patent/MX351290B/es active IP Right Grant
- 2010-11-29 TR TR2018/02921T patent/TR201802921T4/tr unknown
- 2010-11-29 UA UAA201206757A patent/UA106775C2/uk unknown
- 2010-11-29 KR KR1020127016881A patent/KR101742140B1/ko active IP Right Grant
- 2010-11-29 US US13/510,962 patent/US20120309725A1/en not_active Abandoned
- 2010-11-29 CN CN2010800629013A patent/CN102724974A/zh active Pending
- 2010-11-29 SI SI201031645T patent/SI2506844T1/en unknown
- 2010-11-29 SG SG2012038998A patent/SG181087A1/en unknown
- 2010-11-29 NZ NZ600026A patent/NZ600026A/en unknown
- 2010-11-29 LT LTEP10781527.6T patent/LT2506844T/lt unknown
- 2010-11-29 BR BR112012012925A patent/BR112012012925A2/pt not_active Application Discontinuation
- 2010-11-29 PE PE2012000740A patent/PE20130042A1/es active IP Right Grant
- 2010-11-29 CA CA2781487A patent/CA2781487C/en active Active
- 2010-11-29 CN CN201710221222.XA patent/CN107412229A/zh active Pending
- 2010-11-29 ME MEP-2018-45A patent/ME02965B/me unknown
- 2010-11-29 AU AU2010326798A patent/AU2010326798B2/en active Active
- 2010-11-29 PT PT107815276T patent/PT2506844T/pt unknown
- 2010-11-29 RS RS20180166A patent/RS56848B1/sr unknown
- 2010-11-29 EP EP17206132.7A patent/EP3335707B1/en active Active
- 2010-11-29 EA EA201290266A patent/EA023839B1/ru not_active IP Right Cessation
- 2010-11-29 KR KR1020177014116A patent/KR101830728B1/ko active IP Right Grant
- 2010-11-29 SG SG10201407864UA patent/SG10201407864UA/en unknown
- 2010-11-29 ES ES10781527.6T patent/ES2659330T3/es active Active
- 2010-11-29 PE PE2017000991A patent/PE20170915A1/es unknown
- 2010-11-29 JP JP2012541445A patent/JP5816631B2/ja active Active
-
2012
- 2012-05-20 IL IL219893A patent/IL219893A/en active IP Right Grant
- 2012-05-22 CR CR20120265A patent/CR20120265A/es unknown
- 2012-05-28 ZA ZA2012/03890A patent/ZA201203890B/en unknown
- 2012-05-28 CO CO12088319A patent/CO6541613A2/es unknown
- 2012-05-30 DO DO2012000148A patent/DOP2012000148A/es unknown
- 2012-05-31 CL CL2012001432A patent/CL2012001432A1/es unknown
- 2012-06-28 MA MA35016A patent/MA33853B1/fr unknown
-
2014
- 2014-07-16 AU AU2014204459A patent/AU2014204459B2/en active Active
-
2015
- 2015-12-16 US US14/970,945 patent/US9750726B2/en active Active
-
2016
- 2016-11-23 AU AU2016262698A patent/AU2016262698B2/en active Active
-
2017
- 2017-08-16 US US15/678,246 patent/US11090294B2/en active Active
-
2018
- 2018-02-06 CY CY20181100149T patent/CY1120058T1/el unknown
- 2018-02-21 HR HRP20180312TT patent/HRP20180312T1/hr unknown
- 2018-05-31 CY CY2018017C patent/CY2018017I1/el unknown
- 2018-05-31 FR FR18C1022C patent/FR18C1022I2/fr active Active
- 2018-06-04 LU LU00077C patent/LUC00077I2/en unknown
- 2018-06-07 LT LTPA2018011C patent/LTC2506844I2/lt unknown
- 2018-06-14 HU HUS1800027C patent/HUS1800027I1/hu unknown
- 2018-06-22 HK HK18108027.0A patent/HK1249407A1/zh unknown
- 2018-12-21 AU AU2018282427A patent/AU2018282427C1/en active Active
-
2020
- 2020-02-04 US US16/781,587 patent/US20200171009A1/en not_active Abandoned
-
2021
- 2021-06-24 AU AU2021204302A patent/AU2021204302A1/en not_active Abandoned
- 2021-10-29 US US17/514,685 patent/US20220047565A1/en not_active Abandoned
-
2022
- 2022-04-06 US US17/714,241 patent/US20220235087A1/en active Pending
-
2023
- 2023-08-24 AU AU2023219901A patent/AU2023219901A1/en active Pending
- 2023-10-12 US US18/485,799 patent/US20240041846A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6541613A2 (es) | Combinaciones de un antagonista de los receptores muscarínicos y un agonista del adreno-receptor beta 2 | |
ECSP066940A (es) | Antagonistas del receptor de acetilcolina muscarínico | |
CY1118040T1 (el) | Συνθεσεις για πνευμονικη απελευθερωση μακροχρονιως-δρωντων μουσκαρινικων ανταγωνιστων και μακροχρονιως-δρωντων αγωνιστων β2 αδρενεργικων υποδοχεων και συσχετιζομενες μεθοδοι και συστηματα | |
MX2010002781A (es) | Combinacion novedosa de angentes terapeuticos. | |
SV2011003891A (es) | Antagonistas de los receptores tipo toll 3 | |
CL2011000976A1 (es) | Compuestos derivados de isonicotinamida y carboxamida, antagonistas de los receptores de orexina; composicion farmaceutica que los comprende; y su uso para la prevencion de un trastorno del sueno. | |
UY31124A1 (es) | Derivados de oxiadazol y su uso como potenciadores del receptor metabotropico de glutamato - 842 | |
HN2008000178A (es) | Compuestos triciclicos, composiciones y procedimientos | |
CL2012000702A1 (es) | Uso de un agonista del receptor de acetilcolina nicotinico alfa-7 para el tratamiento de la discinesia asociada a la terapia con agonista de dopamina en la enfermedad de parkinson. | |
BRPI1008060A2 (pt) | Agonistas e antagonistas do receptor s1p5, e métodos de uso do mesmo. | |
ECSP11010814A (es) | Derivados de ciclohexil-amida y su uso como antagonistas de los receptores de crf-1 | |
CL2009000873A1 (es) | Compuestos derivados de ciclohepta[b]piridina, antagonistas del receptor de cgrp; composicion farmaceutica; y uso para el tratamiento de la migrana.b | |
CL2008003159A1 (es) | Compuestos derivados de diaminas sustituidas, sus sales farmaceuticamente aceptables o sus solvatos; compuestos intermediarios; utiles como agentes antiobesidad, mediados por la inhibicion del receptor npy y5. | |
CL2008000905A1 (es) | Compuestos derivados de morfina, antagonistas del receptor opioide periferico; metodo de preparacion; composicion farmaceutica; y uso para reducir los efectos de la actividad opioide endogena. | |
CY1120661T1 (el) | Ανταγωνιστες υποδοχεα 5-ητ3 σεροτονινης για χρηση στη θεραπεια των αλλοιωτικων αιθουσαιων διαταραχων | |
CL2008002450A1 (es) | Compuestos derivados de fenil-pirrolidin-eter, con actividad antagonista de los receptores nk3; procedimientos para su preparacion; composicion farmaceutica; y el uso de los compuestos en el tratamiento de depresion, dolor, psicosis, entre otras. | |
ECSP088265A (es) | Derivados de carboxamida como antagonistas del receptor muscarínico | |
AR074369A1 (es) | Anticuerpos anti-unc 5b (receptor de netrina) y metodos de uso | |
DE602007004999D1 (de) | 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulen-derivate als orexinrezeptor-antagonisten | |
CR20110642A (es) | Antagonistas del receptor tipo toll 3 | |
CL2016002240A1 (es) | Derivados de piperidina como antagonista de receptores de orexina | |
CL2008003266A1 (es) | Compuestos derivados de pirimidindiona y triazindiona sustituidas con cicloguanidina, utiles como antagonista del receptor de procineticina; composicion farmaceutica que comprende dichos compuestos; y uso en el tratamiento de enfermedades gastrointestinales. | |
UY32520A (es) | Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides | |
BR112012002445A2 (pt) | uso de um agonista do receptor 4 de melanocortina. | |
EP2032127A4 (en) | TREATMENT OF PSYCHOLOGICAL PATHOLOGIES USING M1 MUSCARINIC RECEPTOR ANTAGONISTS |